Wall Street analyst estimates for Aditxt, Inc. (ADTX): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
Aditxt, Inc. is a biotechnology firm dedicated to advancing immune system health through innovative mapping and reprogramming techniques. The company's developments include AditxtScore, a platform designed to empower individuals by providing insights into their immune profiles for better management and informed awareness of immune system attacks or dysfunctions.
Valuation Ratios
| Price / Book | -0.00 |
| EV / EBITDA | -0.24 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | $105034 | $933715 | $645176 | $133985 | $3195 |
| Cost of Revenue | 0 | 0 | 0 | $17773 | $77979 | $766779 | $756836 | $627474 | $2927 |
| Gross Profit | 0 | 0 | 0 | -$17773 | $27055 | $166936 | -$111660 | -$493000 | $268 |
| Research & Development | 0 | $525000 | $175441 | $937966 | $5.0M | $7.3M | $7.1M | $10.9M | $3.2M |
| Selling, General & Admin | $212986 | $5.1M | $5.7M | $7.9M | $22.4M | $17.8M | $18.9M | $16.5M | $16.4M |
| Operating Expenses | $212986 | $5.6M | $5.9M | $8.9M | $42.0M | $25.6M | $26.0M | $27.4M | $19.6M |
| Operating Income | -$213000 | -$5.6M | -$5.9M | -$8.9M | -$41.9M | -$25.5M | -$26.1M | -$27.9M | -$19.6M |
| EBITDA | $638958 | 0 | $45000 | -$8.8M | -$44.0M | -$24.8M | -$25.5M | -$27.0M | -$40.1M |
| Interest Expense | 0 | $79766 | $1930 | $310081 | $1.9M | $2.3M | $6.4M | $7.4M | $2.4M |
| Pre-tax Income | -$852000 | -$5.7M | -$5.8M | -$9.1M | -$46.4M | -$27.6M | -$32.4M | -$35.0M | -$42.8M |
| Income Tax | -$852000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | -$213000 | -$5.7M | -$5.8M | -$9.1M | -$46.4M | -$27.6M | -$32.4M | -$34.4M | -$41.7M |
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-3062.42 | $-1153.83 |
| EPS (Diluted) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-3062.42 | $-1153.83 |
| Shares Outstanding (Diluted) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $13177 | $37355 |
Price
| Price | $0.01 |
| Market Cap | $5M |
| Exchange | OTC |
| Country | US |
Related companies: AIMD · ANL · APLM · ATHA · BLRX · CTXR · GOVX
Explore sector: Healthcare · Biotechnology
More sections of ADTX: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks